AJR Custom publishing of AJR articles and ARRS Cat. Course
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atwell, T. D.
Right arrow Articles by LeRoy, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atwell, T. D.
Right arrow Articles by LeRoy, A. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.3336
AJR 2008; 191:268-271
© American Roentgen Ray Society


Original Research

Neonatal Thyroid Function After Administration of IV Iodinated Contrast Agent to 21 Pregnant Patients

Thomas D. Atwell1, Aida N. Lteif2, Douglas L. Brown1, Mark McCann3, Jane E. Townsend1 and Andrew J. LeRoy1

1 Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55902.
2 Department of Pediatric Endocrinology and Metabolism, Mayo Clinic, Rochester, MN.
3 Public Health Laboratory, Minnesota Department of Health, St. Paul, MN.

OBJECTIVE. The objective of our study was to document neonatal thyroid function after in utero exposure to nonionic iodinated contrast material to determine the potential risk of subsequent neonatal hypothyroidism.

MATERIALS AND METHODS. We identified pregnant patients ("maternal patient") who underwent CT with iodinated IV contrast material between February 2000 and October 2006. The specifics of the CT examinations were reviewed including patient age, gestational age of conceptus at time of exposure, type of CT, and type and dose of contrast agent. The neonatal serum thyroid-stimulating hormone (TSH) level obtained from the exposed infant ("neonatal patient") was retrieved from the Minnesota Department of Health.

RESULTS. Twenty-one patients gave us consent to review the requested data concerning their 23 children (two mothers had twins). Mean maternal age at the time of CT was 29 years (range, 19–41 years). Mean gestational age (based on last menstrual period) at the time of CT was 23 weeks (range, 8–37 weeks). Neonatal patients were born at a mean of 38 weeks of gestation (range, 24–41 weeks of gestation). Serum TSH was collected at a mean of 43 hours after delivery (range, 24–70 hours). For all neonatal patients, serum TSH levels were normal. Mean serum TSH was 9.7 µIU/mL (range, 2.2–28.8 µIU/mL). No maternal patient reported thyroid trouble in her child.

CONCLUSION. Based on neonatal TSH measurements in a small number of patients, we found no ill effect of iodinated contrast agents on neonatal thyroid function after in utero exposure.

Keywords: contrast media • fetal imaging • hypothyroidism • neonatal imaging • obstetrics • thyroid function • thyroid-stimulating hormone


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.